SARS-CoV-2 With Concurrent Respiratory Viral Infection as a Risk Factor for a Higher Level of Care in Hospitalized Pediatric Patients

From the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: COVID-19 Registry Investigator Group

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

OBJECTIVE: As of early 2021, there have been over 3.5 million pediatric cases of SARS-CoV-2, including 292 pediatric deaths in the United States. Although most pediatric patients present with mild disease, they are still at risk for developing significant morbidity requiring hospitalization and intensive care unit (ICU) level of care. This study was performed to evaluate if the presence of concurrent respiratory viral infections in pediatric patients admitted to the hospital with SARS-CoV-2 was associated with an increased rate of ICU level of care.

DESIGN: A multicenter, international, noninterventional, cross-sectional study using data provided through The Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study database.

SETTING: The medical ward and ICU of 67 participating hospitals.

PATIENTS: Pediatric patients younger than 18 years hospitalized with SARS-CoV-2.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A total of 922 patients were included. Among these patients, 391 required ICU level care and 31 had concurrent non-SARS-CoV-2 viral coinfection. In a multivariate analysis, after accounting for age, positive blood culture, positive sputum culture, preexisting chronic medical conditions, the presence of a viral respiratory coinfection was associated with need for ICU care (odds ratio, 3.6; 95% confidence interval, 1.6-9.4; P < 0.01).

CONCLUSIONS: This study demonstrates an association between concurrent SARS-CoV-2 infection with viral respiratory coinfection and the need for ICU care. Further research is needed to identify other risk factors that can be used to derive and validate a risk-stratification tool for disease severity in pediatric patients with SARS-CoV-2.

Original languageEnglish (US)
Pages (from-to)472-476
Number of pages5
JournalPediatric Emergency Care
Volume38
Issue number9
DOIs
StatePublished - Sep 1 2022

Bibliographical note

Funding Information:
The registry is funded in part by the Gordon and Betty Moore Foundation, and Janssen Research & Development, LLC. They had no influence on analysis, interpretation and reporting of pooled data.

Funding Information:
Disclosure: Includes departmental funds. A.J.W. receives funding from the National Institutes of Health/National Heart, Lung and Blood Institute grants R01HL151607, R01HL139751, R01HL136660, Agency of Healthcare Research and Quality, R01HS026485, Boston Biomedical Innovation Center/NIH/NHLBI 5U54HL119145-07 and royalties from UptoDate. The remaining authors declare no conflict of interest.

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Keywords

  • COVID-19
  • SARS-CoV-2
  • coinfection
  • severe disease
  • Intensive Care Units
  • COVID-19/epidemiology
  • Coinfection
  • Cross-Sectional Studies
  • United States
  • Humans
  • Risk Factors
  • Child

PubMed: MeSH publication types

  • Multicenter Study
  • Journal Article

Fingerprint

Dive into the research topics of 'SARS-CoV-2 With Concurrent Respiratory Viral Infection as a Risk Factor for a Higher Level of Care in Hospitalized Pediatric Patients'. Together they form a unique fingerprint.

Cite this